Journal article 33 views 17 downloads
Experience and views of healthcare professionals towards people who use new psychoactive substances: Evidence from statutory, non‐statutory, and private mental health and addiction healthcare services
,
Jeffrey Grierson,
Lauren Godier‐McBard,
Amira Guirguis
Human Psychopharmacology: Clinical and Experimental, Volume: 38, Issue: 6
Swansea University Author:
Amira Guirguis
-
PDF | Version of Record
© 2023 The Authors. Human Psychopharmacology: Clinical and Experimental published by John Wiley & Sons Ltd. Distributed under the terms of a Creative Commons Attribution 4.0 License (CC BY 4.0).
Download (885.89KB)
DOI (Published version): 10.1002/hup.2883
Abstract
Objective: It is unclear how healthcare professionals (HCPs) experience and view the challenges of working with people who use New Psychoactive Substances (PWUNPS), in different healthcare services (HCS). The aim of the study was to explore HCPs' experiences of working with individuals who use...
| Published in: | Human Psychopharmacology: Clinical and Experimental |
|---|---|
| ISSN: | 0885-6222 1099-1077 |
| Published: |
Wiley
2023
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa64639 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract: |
Objective: It is unclear how healthcare professionals (HCPs) experience and view the challenges of working with people who use New Psychoactive Substances (PWUNPS), in different healthcare services (HCS). The aim of the study was to explore HCPs' experiences of working with individuals who use NPS across statutory, non-statutory, and private mental health and addiction HCSs. Methods: HCPs completed in-depth semi-structured interviews. Audio recordings were transcribed verbatim with a mean duration of 30 min 55 s. Data were analysed through thematic analysis. Results: A purposive sample of 14 HCPs (6 men, 8 women) with a mean age of 42.5 years were interviewed in 2019. Organisational issues, including funding, impacted the treatment for PWUNPS and HCPs perceived a lack of support dependent on their qualifications. They reported a lack of assessment, policy, harm reduction, and awareness of NPS-related symptoms including mental health problems and stigma faced by PWUNPS. Conclusion: HCPs need better training, education, and assessment processes to manage acute NPS intoxications and address the stigma associated with PWUNPS. There is a need for policy-making opportunities across different HCSs to ensure better healthcare outcomes for PWUNPS. |
|---|---|
| Keywords: |
Experiences, healthcare professionals, healthcare services, new psychoactive substances, views |
| College: |
Faculty of Medicine, Health and Life Sciences |
| Issue: |
6 |